"Desvenlafaxine Succinate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
| Descriptor ID |
D000069468
|
| MeSH Number(s) |
D02.033.415.510.500.303 D02.455.426.392.368.367.318.500 D02.455.426.559.389.657.265 D10.289.510.500.303
|
| Concept/Terms |
Desvenlafaxine Succinate- Desvenlafaxine Succinate
- Succinate, Desvenlafaxine
- O-desmethylvenlafaxine Succinate Monohydrate
- Monohydrate, O-desmethylvenlafaxine Succinate
- O desmethylvenlafaxine Succinate Monohydrate
- Succinate Monohydrate, O-desmethylvenlafaxine
- 2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate
- O-desmethylvenlafaxine Succinate
- O desmethylvenlafaxine Succinate
- Succinate, O-desmethylvenlafaxine
WY 45,233- WY 45,233
- 45,233, WY
- WY-45,233
- WY45,233
- WY-45233
- WY45233
- WY 45233
- 45233, WY
Desvenlafaxine- Desvenlafaxine
- O-desmethylvenlafaxine
- O desmethylvenlafaxine
- 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
|
Below are MeSH descriptors whose meaning is more general than "Desvenlafaxine Succinate".
Below are MeSH descriptors whose meaning is more specific than "Desvenlafaxine Succinate".
This graph shows the total number of publications written about "Desvenlafaxine Succinate" by people in this website by year, and whether "Desvenlafaxine Succinate" was a major or minor topic of these publications.
Below are the most recent publications written about "Desvenlafaxine Succinate" by people in Profiles.
-
A randomized controlled trial of desvenlafaxine-induced structural brain changes in the treatment of persistent depressive disorder. Psychiatry Res Neuroimaging. 2023 06; 331:111634.
-
The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: a treatment mechanism study. Lancet Psychiatry. 2019 08; 6(8):667-674.
-
Desvenlafaxine vs. placebo in the treatment of persistent depressive disorder. J Affect Disord. 2019 02 15; 245:403-411.
-
Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study. J Clin Sleep Med. 2017 Feb 15; 13(2):205-213.
-
Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms? A meta-analysis and meta-regression of randomized double-blind controlled studies. Ethiop J Health Sci. 2014 Jul; 24(3):209-18.
-
False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine. Clin Chem. 2002; 48(4):676-7.